Canadian study warns against breast cancer drug that can weaken brain function

. Common medications can cause a stroke

NEW YORK (Reuters Health) – A drug used to treat breast cancer can affect brain function in patients, according to a recent study by researchers at the University of Toronto.
The results were published in the latest issue of the Journal of Neuroscience.
The team studied the side effects of letrozole, widely used to treat breast cancer, on the brain.
The study focused on a group of monkeys with breast cancer and the effects of LTO on the nervous system. The team noted that LTO had an effect on neuronal function in the hippocampus and had resulted in an imbalance of spatial memory.
"The results of the study have led us to further our research on estrogen-targeted breast cancer treatments to monitor their effects on the brain," said Dr. Nicole Gervais, responsible for the study. Research Team.
Lactoseol is used to prevent the recurrence of breast cancer by intervening in the production of estrogen, which interferes with its production to prevent the spread of breast tumors.
According to the International Agency for Research on Cancer of the World Health Organization, breast cancer is the most common type of tumor among women in the world and the Middle East in particular. About 1.4 million new cases are diagnosed each year, killing more than 450,000 women annually worldwide.
;